These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6131437)

  • 1. MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog.
    Sander GE; Kastin AJ; Giles TD
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1301-3. PubMed ID: 6131437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine-enkephalin: reversal of intrinsic cardiovascular stimulation by pentobarbital.
    Sander G; Giles T; Kastin A; Kaneish A; Coy D
    Eur J Pharmacol; 1982 Mar; 78(4):467-70. PubMed ID: 7075679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal administration of delta receptor agonists in the urethane anesthetized rat provokes an increase in arterial pressure via a non-opioid mechanism.
    Rochford J; Henry JL
    Brain Res; 1990 Apr; 512(2):259-68. PubMed ID: 2162234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.
    Giles T; Sander G; Merz H
    Eur J Pharmacol; 1983 Nov; 95(3-4):247-52. PubMed ID: 6197313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular activities of intravenous methionine-enkephalin-Arg6-Phe7 and methionine-enkephalin-Arg6-Gly7-Leu8 in the conscious dog.
    Sander GE; Giles TD
    Life Sci; 1985 Jun; 36(23):2201-7. PubMed ID: 3889529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of leucine-enkephalin with alpha-adrenoceptors in the conscious dog.
    Giles TD; Sander GE
    Chest; 1983 Feb; 83(2 Suppl):364-6. PubMed ID: 6295713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The opioid activity and receptor selectivity of fluorinated Leu5 enkephalin analogues in vitro and in vivo.
    Watanabe J; Tokuyama S; Takahashi M; Kaneto H; Maeda M; Kawasaki K; Taguchi T; Kobayashi Y; Yamamoto Y; Shimokawa K
    J Pharmacobiodyn; 1991 Feb; 14(2):101-5. PubMed ID: 1651391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog.
    Giles TD; Sander GE
    Peptides; 1983; 4(2):171-5. PubMed ID: 6137809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary pharmacology of enkephalins in the conscious dog.
    Sander GE; Giles TD; Kastin AJ; Quiroz AC; Kaneish A; Coy DH
    Peptides; 1981; 2(4):403-7. PubMed ID: 7329820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of barbiturates upon the hemodynamic responses to intravenous methionine-enkephalin in dogs: modulation by the GABA complex.
    Sander GE; Lowe RF; Giles TD
    Peptides; 1986; 7(2):259-65. PubMed ID: 3016681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cardiovascular responses to intravenous capsaicin, phenyldiguanide, veratrum alkaloids and enkephalins in the conscious dog.
    Giles TD; Sander GE
    J Auton Pharmacol; 1986 Mar; 6(1):1-7. PubMed ID: 3957949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalin analogs and dermorphin in the conscious dog: structure-activity relationships.
    Sander GE; Giles TD
    Peptides; 1982; 3(6):1017-21. PubMed ID: 7167398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
    Gergen KA; Zadina JE; Kastin AJ; Paul D
    Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-allylnormetazocine: hemodynamic actions and inhibition of leucine-enkephalin hemodynamic activity in conscious dogs.
    Given MB; Sander GE; Lowe RF; Giles TD
    J Pharmacol Exp Ther; 1988 Dec; 247(3):850-6. PubMed ID: 3204519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate receptor antagonism by L-prolyl-L-leucyl-glycinamide, MIF-I.
    Dickinson SL; Slater P
    Peptides; 1980; 1(4):293-9. PubMed ID: 6117839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary vascular effects of Leu5-enkephalin in conscious newborn lambs.
    Kulik TJ; Johnson DE; Lock JE
    Peptides; 1985; 6(1):1-5. PubMed ID: 3991356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of opioid peptides on respiration and analgesia in rats.
    Flórez J; Pazos A
    Life Sci; 1982 Sep 20-27; 31(12-13):1275-7. PubMed ID: 6292613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MIF-I's differential actions as an opiate antagonist.
    Kastin AJ; Olson RD; Ehrensing RH; Berzas MC; Schally AV; Coy DH
    Pharmacol Biochem Behav; 1979 Dec; 11(6):721-3. PubMed ID: 43981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.